Patients with psoriasis and NAFLD were also more likely to have higher circulating levels of C-reactive protein, IL-6 and lower adiponectin levels than those without NAFLD. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.